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Abstract Germ cell nuclear factor (GCNF) is an orphan
member of the nuclear receptor gene superfamily. We report
the cloning of a cDNA encoding a new variant of human GCNF
from human testis and its expression analysis. Southern blot
analysis of the human genomic DNA indicates that the GCNF
gene is not closely related to other members within the nuclear
receptor superfamily. Chromosomal localization of the GCNF
gene shows that the gene is located on chromosome 9 at the locus
q33^34.1. In situ hybridization analysis of GCNF expression in
the testis shows that human GCNF is expressed exclusively in
germ cells.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Members of the nuclear receptor gene superfamily, which
are ligand-activated transcription factors, are involved in the
regulation of development, growth, and reproduction [1^3].
Orphan receptors form a part of the nuclear receptor gene
superfamily [3^7]. Structurally, orphan receptors share several
common functional traits with the steroid receptors. Most of
the orphan receptors have a DNA binding domain (DBD)
and a putative ligand binding domain (LBD), although there
are a few exceptions to this general rule. For example, DAX1
contains only a LBD related to nuclear receptors [8], whereas
the Drosophila orphan receptor Knirps [9] and related genes
contain only a DBD. For the majority of the orphans, lig-
ands, and therefore possible mechanisms of activation, remain
unknown. These so-called orphan nuclear receptors are found
in all metazoan species, and some of them will likely interact
with novel ligands, while others may be activated by post-
transcriptional modi¢cations in ligand-independent manners
or by heterodimerization with active receptor partners, e.g.
LXR and RXR [10].
It has been shown that orphan receptors play important
physiological roles in the development, di¡erentiation and
homeostasis of many organisms. For example, FTZ-F1 null
mutant mice lack gonads and adrenal glands and die during
the ¢rst days of life, probably due to the absence of the adre-
nal function [11^14]. Loss-of-function mutations of DAX-1
have been identi¢ed as the genetic cause of the X-linked adre-
nal hypoplasia congenita and X-linked hypogonadotropic hy-
pogonadism, characterized by structural abnormalities of the
adrenal glands and gonads, resulting in impaired steroidogen-
esis [8,15]. HNF4 expression in the adult is restricted to the
liver, kidney, and intestine [16]. However, HNF4 null mutants
die at approximately 8.5 dpc and exhibit extensive cell death
in the ectoderm at 6.5 dpc [17]. The orphan receptors COUP-
TFI and COUP-TFII are transcriptional repressors that have
been highly conserved during evolution [18^21]. COUP-TFI
mutants die perinatally, and COUP-TFII mutants die in utero
[22]. Dramatic phenotypes of the null mutants of the orphan
receptors illustrate their importance in every step of develop-
ment and functioning of an organism.
Germ cell nuclear factor (GCNF) is a novel orphan recep-
tor that is not closely related to other family members [23^25].
The expression of mouse GCNF (mGCNF), in the adult, is
predominantly germ cell speci¢c [23]. It is expressed in the
oocytes of growing follicles in females and after the comple-
tion of the meiosis in round spermatids in males [23,26]. High
level of expression of the human homolog was detected by the
Northern blot analysis only in testis and lower levels of ex-
pression were found in prostate ovary and colon [27,28]. The
smaller message is 2.2 kbp in the human whereas it is 2.4 kbp
in the mouse. The major di¡erence between the size of the two
messages is due to the N-terminal exon variations and the
length of the 3P untranslated region. It is known that the
di¡erences in the two messages in the mouse lies in the 3P
untranslated region [26]. The di¡erent 3P untranslated regions
may allow di¡erential translation of the messages, which in
the testis is an important mechanism for the regulation of
expression [29]. Since the two messages are maintained in
both species it implies that the possible post-transcriptional
regulation of GCNF expression in germ cells may be impor-
tant in regulating its function. The very speci¢c pattern of
expression suggests an important function for GCNF in
germ cell di¡erentiation. To investigate the pattern of expres-
sion and possible role of the GCNF in human gametogenesis
we have cloned cDNA encoding the human GCNF (hGCNF)
gene using the mGCNF cDNA as a probe. In situ hybrid-
ization studies show that the expression of GCNF in testis is
restricted to germ cells, the spermatids and late stage sperma-
tocytes.
2. Materials and methods
2.1. Cloning of the complementary DNA and sequencing
106 clones from an adult human testis random primed cDNA li-
brary (Clontech, Palo Alto, CA) were plated out and screened at low
stringency with a 2 kbp cDNA fragment (nucleotides 189^2602) en-
coding mouse GCNF. Hybridizations were performed at 60‡C over-
night in Church bu¡er (0.5 M sodium phosphate pH 7.4, 7% SDS)
and were followed by three washes at 60‡C for 30 min in
1USSC:0.1% SDS. The Marathon Ready cDNA kit (Clontech,
Palo Alto, CA) was used to clone the missing 5P end of the open
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reading frame (ORF) of the GCNF gene, according to the manufac-
turer’s protocol. The gene speci¢c primer used for the ampli¢cation
was PN2 CAGCTGGTGAATCAGACTGT positioned between nu-
cleotides 879^860. The PCR fragments generated by this procedure
were subcloned into pCRII vector (Invitrogen) and double-stranded
dideoxy sequenced using Sequenase 2.0 kit (Amersham) and several
forward and reverse primers.
2.2. Southern blot analysis
Southern blot analysis was performed using a Human GENO-
BLOT (Clontech, Palo Alto, CA) Southern blot of human genomic
DNA digested with the BglII, PstI, BamHI, HindIII, and EcoRI re-
striction endonucleases. The probe used was hNF5 cDNA between
803^1860 nucleotides hGCNF. The hybridization was performed in
Church bu¡er overnight at 65‡C and was followed by three 30 min
washes in 1USSC, 0.1% SDS at 65‡C, and one 30 min wash in
0.1USSC, 0.1% SDS at 65‡C. The ¢lter was exposed to X-ray ¢lm
(Kodak XAR-5) overnight.
2.3. Radioactive in situ hybridization
Testis biopsies were obtained from brain dead organ donors donat-
ing tissue for transplantation and research, in compliance with the
University of Illinois at Chicago Institutional Review Board human
and animal protocols, and the Regional Organ Bank of Illinois. Tissue
was ¢xed by immersion for 18 h in the ¢xative that includes 3.5%
paraformaldehyde, 0.15% glutaraldehyde in phosphate bu¡er (pH 7.2)
with 2% added sucrose. After ¢xation, the tissue was washed brie£y
with phosphate bu¡er, dehydrated in graded ethanol series, and par-
a⁄n embedded for sectioning (3^4 Wm).
The probe used was the part of the hGCNF clone spanning nucleo-
tides 803^1860 of hGCNF. GCNF antisense and sense (negative con-
trol) riboprobes were generated from BamHI and XhoI linearized
GCNF in pCRII (Invitrogen). The Gemini System II (Promega) kit
was used with T7 RNA polymerase site 1 and with the BamHI line-
arized plasmid to generate antisense probe, and with Sp6 RNA po-
lymerase with the XhoI linearized plasmid to generate sense probe. P-
33 was used for all nucleotide labeling.
Sections were dewaxed in xylene and rehydrated with graded etha-
nol, then digested in 0.001% proteinase K at 37‡C for 15 min and then
acetylated with a 0.3% volume/volume solution of acetic anhydride in
0.1 M triethanolamine (pH 8.0), rinsed in 2USSC and dehydrated in
graded ethanol. Sections were then hybridized in 107 dpm/ml ribo-
probe in a bu¡er of 50% formamide, 10% dextran sulfate, 0.3 M
NaCl, 1UDenhardt’s, 10 mM Tris (pH 8.0), 1 mM EDTA (pH
8.0), 0.5 mg/ml Escherichia coli tRNA and 10 mM DTT for 20 h at
56‡C. Slides were then rinsed in 4USSC and digested in 0.02 mg/ml
RNase A for 30 min at 37‡C, gradually desalted in SSC with 1 mM
DTT, and incubated in 0.1USSC with 1 mM DTT for 30 min at
60‡C. Slides were dehydrated in graded ethanol, then dipped in photo-
graphic emulsion (Kodak NTB-2), exposed for 8 weeks at 4‡C in total
darkness, developed, and counterstained with hematoxylin and eosin.
2.4. Chromosomal localization
Human BAC genomic DNA library was screened by PCR with
GCNF speci¢c primers PN12 (CATCTTCAATCAACATGGGCG)
and PN13 (TCTGTGGAACTGAATGGATTCATG). The resulting
BAC clone was used for preparation of the non-isotopically labeled
probe and £uorescent in situ hybridization [30].
3. Results
3.1. Cloning of the human GCNF cDNA
A human testis complementary DNA library (Clontech,
Palo Alto, CA), made from the testis of four adult healthy
males, was screened with a 32P-labeled probe containing the
mGCNF cDNA sequence. Identi¢ed clones were ampli¢ed
with the primers speci¢c to the vector in which the library
was constructed (Vgt11), then subcloned into the pCRII vec-
tor (Invitrogen, Carlsbad, CA), and subsequently sequenced.
The sequences were analyzed using the Best¢t program from
the GCG package (Wisconsin Package Version 9.0-UNIX).
Sequence analysis of the ¢ve clones obtained from the screen
of the human testis cDNA library showed that they were
overlapping clones with identical sequence in the regions of
overlap. Sequence comparison showed that these clones were
highly homologous to the mGCNF, however all of them
lacked the 5P end of the ORF and the 5P untranslated region.
The longest clone, hNF5, spanned nucleotides 803^1860 of
hGCNF. To obtain a full length copy of the hGCNF
cDNA a Marathon Ready cDNA library was ampli¢ed with
a hGCNF speci¢c primer PN2 and the adapter primer AP2
supplied in the Marathon Ready cDNA kit (PT1156-1, Clon-
tech, Palo Alto, CA). The hGCNF cDNA ORF encodes a 454
amino acid polypeptide with a predicted molecular weight of
52 kDa.
At least three di¡erent variants of hGCNF have been
cloned in di¡erent laboratories (Fig. 1) [27,31]. All variants
are identical in the DBD and LBD and thus do not represent
orphan receptor isoforms encoded by separate genes, but
rather represent di¡erential intron/exon splicing of pre
mRNA derived from a single hGCNF gene. The hGCNF
cDNA we have cloned has a 22 amino acid deletion in the
N-terminus of the domain relative to the other three variants.
It also has a four amino acid deletion found in one of the
other variants (S83309). The functional signi¢cance of these
N-terminal variations is, at present, unknown, but may lead
to di¡erential transactivation or DNA binding properties.
3.2. Analysis of the hGCNF gene structure and chromosomal
localization
Southern blot analysis of the human genomic DNA showed
that the hGCNF probe hybridizes as a single band with the
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Fig. 1. Comparative analysis of the amino acid sequence of hGCNF. Comparison of the ¢rst 100 amino acids of hGCNF variants. The ¢rst
100 amino acids contain the amino-terminal domain and part of the DNA binding domain. Four di¡erent variants of hGCNF have been re-
ported to date, which di¡er only in the structure of the amino-terminal domain of the protein. The hGCNF variant reported here (AF 004291)
has two deletions (dots and squiggles) compared to the hGCNF variants hsu64876 and hsu80802, but has a common deletion (dots) with the
hGCNF variant s83309.
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EcoRI digested DNA and two bands with BamHI digested
DNA, which is consistent with the restriction map of the
hGCNF cDNA (Fig. 2). These results indicate that GCNF
is most likely a unique gene. No substantial homology to
any other sequences was apparent from the Southern blot
analysis. It exhibits several additional weaker bands in the
lanes of the DNA digested with BamHI and BglII. The
mGCNF gene has several very small exons (Cooney and
Katz, unpublished results), therefore the weak bands on the
Southern blot might be a result of the hybridization to the
very small exons of the hGCNF gene.
In order to determine on which human chromosome the
hGCNF gene is localized and the speci¢c locus within that
chromosome, chromosomal localization was employed. Using
FISH analysis the GCNF gene was localized to chromosome
9 at the q33^34.1 locus (Fig. 3). At present, of the inherited
diseases that have been located to that region of chromosome
9 none of the disease etiologies ¢ts with what is known of the
biology of GCNF.
3.3. Analysis of the expression pattern of hGCNF
By Northern blot analysis several groups have demon-
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Fig. 3. Chromosomal localization of the hGCNF gene. A BAC clone, obtained after PCR screening of a human genomic DNA library, was
non-isotopically labeled and used as a probe in the £uorescent in situ hybridization. The chromosomes were counterstained with DAPI. Images
were obtained using cool-CCD camera. The yellow signal (arrows) represents a position of the gene on the chromosome. It is apparent on a
single chromosomal pair (chromosome 9) between the bands q33 and q34.1.
Fig. 2. Southern blot analysis of the hGCNF gene. A human
GENO-BLOT (Clontech) was probed with the hGCNF cDNA at
high stringency. The size of the molecular weight marker bands is
indicated on the right.
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strated high level of hGCNF expression in testis and some
expression in the ovary, colon and prostate [31,32]. We have
observed similar results. To determine the speci¢c cells within
the testis in which the GCNF message is localized we em-
ployed in situ hybridization. Both sense and antisense ribo-
probes were generated from the hNF5 clone. No signi¢cant
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Fig. 4. In situ hybridization analysis of the expression of hGCNF in human testis. A: Light ¢eld of the human testis histology stained with
hematoxylin and eosin. B: Dark ¢eld of the section shown in A probed with a P-33 antisense riboprobe to hGCNF. A strong signal (white sil-
ver grains) is clearly detected within the seminiferous tubules. C: Light ¢eld of the human testis histology stained with hematoxylin and eosin.
D: Dark ¢eld of the section shown in C probed with a P-33 sense riboprobe to hGCNF. Only backgound signal is detected. E: High magni¢-
cation of the light ¢eld of a testis section probed with P-33 antisense riboprobe to GCNF (A). A strong signal (silver grains, black dots) was
detected in the spermatogenic cells (arrows).
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signal above background was observed in the in situ hybrid-
ization of the human testis with the hGCNF sense probe (Fig.
4D). In contrast a strong and speci¢c signal, with the anti-
sense probe to hGCNF, was observed in the seminiferous
tubules of the human testis (Fig. 4B). The expression of the
hGCNF gene was restricted to spermatogenic cells (Fig. 4E).
In spermatogenic cells the expression of GCNF appears to be
strongest in late spermatocytes (Fig. 4E, arrows) with less
signal over the spermatids. Thus, in the testis the hGCNF
gene is expressed in a germ cell speci¢c of manner in round
spermatids and late stage spermatocytes.
4. Discussion
As previously described mGCNF is a germ cell speci¢c
orphan receptor in the adult mouse. In male germ cells it is
expressed postmeiotically in round spermatids. In oocytes its
expression is detected mid meiosis in growing follicles [17,26].
Here we report the cloning of a novel human GCNF homo-
log, analysis of its expression by the in situ hybridization,
chromosomal localization.
By the £uorescent in situ hybridization we have mapped
hGCNF to chromosome 9 locus q33^34.1 and mouse
GCNF to chromosome 2 (Cooney, unpublished data). Com-
prehensive linkage analysis revealed no human or mouse ab-
normalities of the tissues in which GCNF was detected.
Southern blot analysis indicates that there are no closely re-
lated members in that subgroup of the orphan receptors. A
combination of the results of the linkage analysis, the ex-
tremely high homology among evolutionarily distant species,
and the fact that GCNF null mutant mice die prenatally
(Cooney and Katz, personal communication) suggest an im-
portant non-redundant function of GCNF in development.
Chromosomal FISH experiments resulted in a single local-
ization site. In addition, the fact that the DBDs and LBDs are
identical in all hGCNF variants indicates that they do not
represent orphan receptor isoforms encoded by separate
genes, but rather are probably a result of a di¡erential in-
tron/exon splicing of pre-mRNA derived from a single
hGCNF gene.
Four reported isoforms provide evidence for alternate exon
splicing in the N-terminal part of the human homolog (Fig.
1). At least three di¡erent variants have been cloned in other
laboratories. The hGCNF cDNA we have cloned lacks 22
amino acids in the N-terminus region relative to the other
three variants. It also has a four amino acid deletion found
in one of the other variant (S83309). The functional signi¢-
cance of the N-terminal variations are at present is unknown.
There is evidence that the N-terminus of GCNF modulates
DNA binding: in the absence of the N-terminus GCNF can
bind DNA as a monomer whereas a intact receptor binds
DNA only as a dimer (Cooney, personal communication).
Multiple N-terminal variants of hGCNF may therefore have
a di¡erent DNA binding characteristics.
The in situ hybridization studies showed that like in mouse
the expression of hGCNF in testis is restricted to the germ
cells. In contrast to rodents, the expression of hGCNF is not
restricted to post-meiotic germ cells [23,26]. In human germ
cells GCNF is expressed pre-meiotically in spermatocytes. In
fact the in situ analysis seems to indicate that the highest
levels of GCNF expression is in the late stage spermatocytes.
In the mouse and rat there is a peak of expression of GCNF
in round spermatids at stages VII and VII, respectively. These
stages are some of the last round spermatid stages prior to
elongation. The di¡erence in the temporal expression in sper-
matogenesis of the human homolog versus the rodents is
probably due to underlying di¡erences in spermatogenesis in
these species.
In the gonads, exclusive germ cell expression of the GCNF
in the developing gametes allows us to postulate that GCNF
is an important factor in spermatogenic maturation. Due to
the similarity of the GCNF pattern of expression in men and
mice, the mouse is a good model to study its role in the
spermatogenesis and fertility. To determine this cell speci¢c
knock outs of GCNF in oocytes and spermatogenic cells are
being generated. These studies will show whether or not fer-
tility could be modi¢ed by targeting the GCNF signaling
pathway. To address the possible role of GCNF in the abnor-
mal germ cell development the study of GCNF expression in
various germ cell tumors is now under way.
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